Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis-Specific Transcriptional Signatures in Human Skin.
Trinh-Minh T, Györfi AH, Tomcik M, Tran-Manh C, Zhou X, Dickel N, Tümerdem BS, Kreuter A, Burmann SN, Borchert SV, Hussain RI, Hallén J, Klingelhöfer J, Kunz M, Distler JHW. Trinh-Minh T, et al. Among authors: klingelhofer j. Arthritis Rheumatol. 2024 May;76(5):783-795. doi: 10.1002/art.42781. Epub 2024 Feb 15. Arthritis Rheumatol. 2024. PMID: 38108109
S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.
Švec X, Štorkánová H, Trinh-Minh T, Tran MC, Štorkánová L, Hulejová H, Oreská S, Heřmánková B, Bečvář R, Pavelka K, Vencovský J, Klingelhöfer J, Hussain RI, Hallén J, Šenolt L, Distler JHW, Tomčík M. Švec X, et al. Among authors: klingelhofer j. Rheumatology (Oxford). 2024 Mar 1;63(3):817-825. doi: 10.1093/rheumatology/kead295. Rheumatology (Oxford). 2024. PMID: 37314987 Free PMC article.
Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor.
Ganaie AA, Mansini AP, Hussain T, Rao A, Siddique HR, Shabaneh A, Ferrari MG, Murugan P, Klingelhöfer J, Wang J, Ambartsumian N, Warlick CA, Konety BR, Saleem M. Ganaie AA, et al. Among authors: klingelhofer j. Mol Cancer Ther. 2020 Dec;19(12):2598-2611. doi: 10.1158/1535-7163.MCT-20-0410. Epub 2020 Sep 30. Mol Cancer Ther. 2020. PMID: 32999046 Free PMC article.
Neurotrophic Effects of Vascular Endothelial Growth Factor B and Novel Mimetic Peptides on Neurons from the Central Nervous System.
Dmytriyeva O, de Diego Ajenjo A, Lundø K, Hertz H, Rasmussen KK, Christiansen AT, Klingelhofer J, Nielsen AL, Hoeber J, Kozlova E, Woldbye DPD, Pankratova S. Dmytriyeva O, et al. Among authors: klingelhofer j. ACS Chem Neurosci. 2020 May 6;11(9):1270-1282. doi: 10.1021/acschemneuro.9b00685. Epub 2020 Apr 27. ACS Chem Neurosci. 2020. PMID: 32283014
The Multifaceted S100A4 Protein in Cancer and Inflammation.
Ambartsumian N, Klingelhöfer J, Grigorian M. Ambartsumian N, et al. Among authors: klingelhofer j. Methods Mol Biol. 2019;1929:339-365. doi: 10.1007/978-1-4939-9030-6_22. Methods Mol Biol. 2019. PMID: 30710284 Review.
The S100A4 Protein Signals through the ErbB4 Receptor to Promote Neuronal Survival.
Pankratova S, Klingelhofer J, Dmytriyeva O, Owczarek S, Renziehausen A, Syed N, Porter AE, Dexter DT, Kiryushko D. Pankratova S, et al. Among authors: klingelhofer j. Theranostics. 2018 Jul 1;8(14):3977-3990. doi: 10.7150/thno.22274. eCollection 2018. Theranostics. 2018. PMID: 30083275 Free PMC article.
123 results